Stryker Corporation (SYK) News
Follow Stryker Corporation (SYK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 56 public stories across 28 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Stryker Announces Dividend of R$ 0.1634822620 per Unit
Stryker announced a third-quarter 2026 dividend of R$ 0.1634822620 per unit.
EQUITY | Nov 03, 2026, 08:37 PM UTC
M
Stryker Completes Acquisition of ZuriMED
Stryker completed its acquisition of ZuriMED, expanding its shoulder repair portfolio.
MNA | Oct 30, 2026, 04:16 PM UTC
H
Stryker Reports Third-Quarter Revenue of $6.52B, EPS of $1.96
Stryker said third-quarter 2026 revenue rose 7.6% year over year to $6.52B, while net income fell 12.3% to $753M and diluted EPS declined 11.7% to $1.96. Sales growth reflected higher unit volumes across several business
EQUITY | Oct 30, 2026, 03:11 PM UTC
M
Stryker Q3 2026 Net Profit Falls 12%
Stryker's net profit fell 12% in the third quarter of 2026.
EQUITY | Oct 29, 2026, 08:39 PM UTC
H
Stryker Q3 Profit Falls to $753 Million
Stryker reported third-quarter profit of $753 million, or $1.96 per share, compared with $859 million, or $2.22 per share, a year earlier.
EQUITY | Oct 29, 2026, 08:39 PM UTC
M
Stryker shares fall 8.5% after lowering annual profit forecast
Stryker shares fell 8.5% to $28 after the company lowered its annual profit forecast.
EQUITY | Oct 29, 2026, 08:25 PM UTC
M
Stryker Reports Third-Quarter Sales of $6.5 Billion
EARNINGS | Oct 29, 2026, 08:25 PM UTC
M
Stryker Reports Q3 Revenue of $6.52B, Below FactSet Estimate
Stryker reported Q3 revenue of $6.52 billion, versus a FactSet estimate of $6.62 billion.
EQUITY | Oct 29, 2026, 08:20 PM UTC
M
Stryker board approves $3B increase to share repurchase program
EQUITY | Oct 29, 2026, 08:15 PM UTC
M
Stryker Posts Q3 Adjusted EPS of $3.52 Per Share
EARNINGS | Oct 29, 2026, 08:13 PM UTC
L
Stryker Reports Q3 EPS of $1.96
EARNINGS | Oct 29, 2026, 08:10 PM UTC
M
Stryker Sees FY Adjusted EPS of $14.80-$14.90
EARNINGS | Oct 29, 2026, 08:06 PM UTC
L
Stryker Reports Third-Quarter Net Income of $753 Million
EARNINGS | Oct 29, 2026, 08:06 PM UTC
M
Stryker Reports Third-Quarter EPS of $1.96
EARNINGS | Oct 29, 2026, 08:06 PM UTC
M
US Equity Futures Trade Lower Before Inflation Report, Amazon Earnings
US equity futures were lower ahead of a key inflation report and Amazon earnings.
EQUITY | Oct 29, 2026, 11:50 AM UTC
L
Stryker Completes ZuriMED Acquisition
Stryker said it completed its acquisition of ZuriMED.
MNA | Oct 26, 2026, 12:53 PM UTC
M
Stryker Completes Acquisition of ZuriMED
Stryker says it has completed its acquisition of ZuriMED to enhance its shoulder offering.
MNA | Oct 26, 2026, 12:05 PM UTC
M
Stryker Q3 Results Preview: Revenue Estimate Is 6.62B USD
Stryker is scheduled to report Q3 results on October 29 after the market closes, with EPS anticipated at 3.55 USD.
EQUITY | Oct 22, 2026, 11:01 AM UTC
L
Stryker launches Sonopet 3 ultrasonic tissue removal system
Stryker says the system delivers greater power and precision in ultrasonic tissue removal.
EQUITY | Oct 14, 2026, 01:05 PM UTC
M
Stryker to Invest $400 Million in CMR Surgical, Secures Acquisition Option
Stryker agreed to invest about $400 million in the British surgical-robotics company and secured an exclusive option to acquire it.
MNA | Oct 12, 2026, 12:43 PM UTC
L
Stryker and CMR Surgical form strategic alliance
The companies say the alliance will advance robotic-assisted surgery.
EQUITY | Oct 12, 2026, 12:00 PM UTC
M
Truist cuts Stryker price target to $310, sees low-risk CEO transition
Truist lowered its price target on Stryker Corp. (SYK) shares to $310 from $340 while maintaining a 'Hold' rating. The firm's analyst indicated that the planned CEO transition is expected to be low-risk.
EQUITY | Oct 06, 2026, 06:01 PM UTC
M
Stryker to announce third-quarter 2026 results
Stryker said it will announce third-quarter 2026 financial results.
EQUITY | Oct 01, 2026, 12:00 PM UTC
L
SYK - Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™
SYK - Stryker showcases Foot & Ankle innovation at AOFAS 2026 with Prophecy® Surgical Planning for Incompass™ and Hoffmann® LRF smartHEX™
NEWS | Sep 16, 2026, 01:06 PM UTC
H
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
Wall Street rallied on Friday after the latest consumer inflation report came in broadly in line with expectations, helping ease concerns over price pressures and supporting a rebound across risk assets.On Friday, the Do
NEWS | Sep 13, 2026, 01:11 PM UTC
L
Stryker price target cut to $360 from $399
EQUITY | Sep 10, 2026, 04:34 PM UTC
L
Stryker kept at Overweight by Wells Fargo
Wells Fargo maintained an Overweight rating on Stryker (SYK).
EQUITY | Sep 09, 2026, 02:27 PM UTC
H
SYK says 2024 guidance unchanged despite supply challenges in key segments
SYK said 2024 guidance remains unchanged despite ongoing supply challenges in peripheral vascular and joint replacement segments. Management cited robust performance in capital and trauma businesses offsetting softness,
EARNINGS | Sep 08, 2026, 04:44 PM UTC
H
Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it w
Shares of medical device-related companies are trading lower amid possible sympathy with Boston Scientific after that company announced it was likely to miss its FY26 and Q3 adjusted EPS and net sales growth guidance fol
EARNINGS | Sep 08, 2026, 04:05 PM UTC
M
Stryker shares slide as peripheral vascular supply remains constrained
Stryker shares fell 8.1% to $278.71 Tuesday after the company said a lack of supply continues to hamper its peripheral vascular business. Shares are down 21% year to date.
EQUITY | Sep 08, 2026, 04:02 PM UTC
H
SYK management reaffirms full-year growth guidance despite segment softness
Management reaffirmed full-year growth guidance, citing demand strength in capital and trauma/extremities businesses offsetting supply-driven softness in peripheral vascular and joint replacement segments.
EARNINGS | Sep 08, 2026, 04:00 PM UTC
L
Stryker to participate in Wells Fargo Healthcare Conference on Sept. 8, 2026
Stryker will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at Encore Boston Harbor, as previously reported.
EQUITY | Sep 04, 2026, 10:38 PM UTC
L
Stryker to participate in Wells Fargo 2026 healthcare conference
Stryker scheduled to participate in the 2026 Wells Fargo Healthcare Conference.
EQUITY | Sep 04, 2026, 10:32 PM UTC
L
SYK introduces FDA-authorized Apple Vision Pro surgical application
Stryker says it introduced an FDA-authorized surgical application for Apple Vision Pro, including a hip arthroscopy case at a nationally recognized academic medical center.
REGULATION | Sep 01, 2026, 01:05 PM UTC
M
Stryker to Acquire ZuriMED
Stryker plans to acquire ZuriMED, according to TradingView News.
MNA | Aug 31, 2026, 08:22 PM UTC
M
SYK signs definitive agreement to acquire ZuriMED
Stryker (SYK) signed a definitive agreement to acquire ZuriMED to enhance its shoulder offering.
MNA | Aug 31, 2026, 08:07 PM UTC
L
Stryker to participate in the 2026 Wells Fargo Healthcare Conference
Stryker says it will participate in the 2026 Wells Fargo Healthcare Conference.
EQUITY | Aug 27, 2026, 07:07 PM UTC
L
SYK - Stryker to participate in the 2026 Wells Fargo Healthcare Conference
SYK - Stryker to participate in the 2026 Wells Fargo Healthcare Conference
EQUITY | Aug 27, 2026, 07:00 PM UTC
L
Clsa, Cantor, RBC, Wolfe, JPM cut ratings on several stocks
Multiple brokers issue rating changes: AMC to Hold at CLSA, BETR to Neutral at Cantor, LENZ to Neutral at BofA, MNPR to Neutral at Cantor, OI to Sector Perform at RBC, SYK to Peer Perform at Wolfe, and TROX to Underweigh
EQUITY | Aug 13, 2026, 10:50 AM UTC
M
Stryker Declares $0.88 Quarterly Dividend
Stryker declares quarterly dividend
EQUITY | Aug 05, 2026, 01:34 PM UTC
H
SYK Q2 Revenue Meets Expectations
SYK Q2 revenue meets expectations
EARNINGS | Jul 31, 2026, 01:03 PM UTC
H
SYK shares retracted ~7% as results came in below consensus on top-line organic growth, and guidance was narrowed @ RBC
SYK shares retracted ~7% as results came in below consensus on top-line organic growth, and guidance was narrowed @ RBC
EQUITY | Jul 31, 2026, 12:13 PM UTC
H
Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 300 points on Friday. Shares of Apple Inc (NASDAQ: AAPL ) fell sharply in pre-market trading after the company posted results for th
EARNINGS | Jul 31, 2026, 12:03 PM UTC
H
MYGN -29%, RBLX -11.6%, FLGT -10.7%, VCYT -9.8%, SYK -9.5%, ALHC -8.6%, COIN -6.5%, RDDT -5.8%, GSIT -5.3%, IR -3.1% after results
MYGN -29%, RBLX -11.6%, FLGT -10.7%, VCYT -9.8%, SYK -9.5%, ALHC -8.6%, COIN -6.5%, RDDT -5.8%, GSIT -5.3%, IR -3.1% after results
EARNINGS | Jul 30, 2026, 08:15 PM UTC
H
SYK Q2 adj EPS $3.69 vs. est. $3.49; Q2 revs $6.59B vs. est. $6.58B; sees FY26 adjusted EPS $14.95-$15.10, vs. consensus $14.97 and says for
SYK Q2 adj EPS $3.69 vs. est. $3.49; Q2 revs $6.59B vs. est. $6.58B; sees FY26 adjusted EPS $14.95-$15.10, vs. consensus $14.97 and says foreign exchange is expected to have a slightly favorable impact on both sales and
EARNINGS | Jul 30, 2026, 08:10 PM UTC
H
SYK Stryker RESULTS: Q2, Q2 net sales $6.600B vs. EST $6.579B, Q2 ADJ EPS $3.69 vs. EST $3.49, Q2 EPS $3.3, Stryker Earnings Notes:, Outlook
SYK Stryker RESULTS: Q2, Q2 net sales $6.600B vs. EST $6.579B, Q2 ADJ EPS $3.69 vs. EST $3.49, Q2 EPS $3.3, Stryker Earnings Notes:, Outlook FY ADJ EPS $14.95-15.1 vs. EST $15, Outlook FY organic net sales growth 8.3-9.3
EARNINGS | Jul 30, 2026, 08:08 PM UTC
H
SYK - Stryker reports second quarter 2026 operating results
SYK - Stryker reports second quarter 2026 operating results
EARNINGS | Jul 30, 2026, 08:08 PM UTC
H
Stryker Raises FY2026 Adj EPS Guidance from $14.90-$15.10 to $14.95-$15.10 vs $14.97 Est
Stryker (NYSE: SYK ) raises FY2026 Adj EPS guidance from $14.90-$15.10 to $14.95-$15.10 vs $14.97 analyst estimate..
EARNINGS | Jul 30, 2026, 08:07 PM UTC
H
Intuit downgrade, Intuitive Surgical upgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled. Top 5 Upgrades: UBS upgraded Intuitive Surgical (I
EARNINGS | Jul 28, 2026, 01:35 PM UTC
L
SYK new Buy W/ $400 PT @ UBS
SYK new Buy W/ $400 PT @ UBS
EQUITY | Jul 28, 2026, 12:47 PM UTC
L
SYK Initiated Buy W/$400.00 PT at UBS
SYK Initiated Buy W/$400.00 PT at UBS
EQUITY | Jul 28, 2026, 11:49 AM UTC
L
BSX DXCM EW GEHC GMED MDT SYK ZBH readthroughs from ABT JNJ ISRG results @ RBC
BSX DXCM EW GEHC GMED MDT SYK ZBH readthroughs from ABT JNJ ISRG results @ RBC
EQUITY | Jul 21, 2026, 12:24 PM UTC
L
SYK Stryker expands Mako Robotics portfolio with full market release of Mako RPS New handheld robotic technology expands the Mako platform a
SYK Stryker expands Mako Robotics portfolio with full market release of Mako RPS New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopa
EQUITY | Jul 16, 2026, 01:09 PM UTC
H
Stryker initiated with an Outperform at BMO Capital
BMO Capital initiated coverage of Stryker with an Outperform rating and $369 price target. The March 2026 cyberattack was an operational disruption, not a demand story, and hospital order books are full, 2026 guidance ha
EARNINGS | Jul 08, 2026, 08:27 PM UTC
L
Evercore ISI Adjusts Price Target on Stryker to $350 From $355
() -- Stryker (SYK) has an average rating of overweight and mean price target of $389.54, according to analysts polled by FactSet. ( covers equity, commodity and economic research from major banks and research firms in N
EQUITY | Jul 06, 2026, 01:05 PM UTC
L
If You Invested $1000 In Stryker Stock 20 Years Ago, You Would Have This Much Today
Stryker (NYSE: SYK ) has outperformed the market over the past 20 years by 1.17% on an annualized basis producing an average annual return of 10.45%. Currently, Stryker has a market capitalization of $120.58 billion. Buy
EQUITY | Jun 30, 2026, 09:15 PM UTC